65 POLYPHARMACY BURDEN IN THE RAPID-ACCESS FRAILTY ASSESSMENT UNIT (RAFAU). (25th October 2022)

• Record Type: Journal Article
• Authors: Kemple, O; Bozic, D; O'Keane, C; Donnelly, T; Doherty, J; McGlynn, J
• Is Part Of: Age and ageing. Volume 51(2022)Supplement 3
• Publication Date: 2022-10-25
• Subjects: Aging -- Periodicals; Geriatrics -- Periodicals; 618.97
• DOI: 10.1093/ageing/afac218.051
• Languages: English
• ISSNs: 0002-0729

Abstract

Abstract: Background: The adverse outcomes associated with polypharmacy (regular use of five or more medications) are well described. One in three over 65 report polypharmacy in Ireland (The Irish Longitudinal Study on Ageing, 2012). A review of the burden of polypharmacy was carried out in a Rapid Access Frailty Assessment Unit (RAFAU) in a regional Irish hospital. Methods: Data was collected on each patient presenting to the RAFAU from May 2021 to March 2022. Each patient was categorised based on number of medications taken. It was recorded whether each patient had a change made to their medications during their review. The inclusion criterion was any patient over 65 presenting to the RAFAU with clear documentation of their medications. Excluded were those without medication lists available. Results: Polypharmacy data was collected in 496 of the total 587 patients attending RAFAU since May 2021. A higher proportion of 59% (n=496) were female. The mean clinical frailty score was four. 100% of the group were reviewed by a doctor. 78.6% of patients were prescribed over five medications. 49.3% of patients were prescribed between 5-10 medications. 22.9% were prescribed 10-15 medications and 6.4% prescribed over 15 medications. 60.8% had a change made to their medication. The incidence of medication changes initiated rose with the increasing number of prescribed medications. 71% of those with more than 15 medications had changes made. Conclusion: The incidence of polypharmacy in those attending RAFAU is extremely high. The frailty unit is an ideal location to review and reduce medication burden as patients have access to a specialist clinician and multidisciplinary team. Although 60% of our patients had medication changes made, we do not use a standard tool in RAFAU to guide medication reduction in frail patients with polypharmacy. It is planned to introduce routine assessment of polypharmacy utilising the STOPP/START tool and re-audit one year after implementation.